Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tango Therapeutics Inc (NQ: TNGX )

7.090 -0.300 (-4.06%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,224,383
Open 6.710
Bid (Size) 6.500 (1)
Ask (Size) 7.080 (46)
Prev. Close 7.390
Today's Range 6.620 - 7.690
52wk Range 2.470 - 13.03
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity
Tango Therapeutics halts its TNG348 program due to liver toxicity issues found in dose escalation studies. The company will now focus on its PRMT5 program and plans to update on TNG908 and TNG462 later... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Performance

YTD
-28.96%
-28.96%
1 Month
-3.01%
-3.01%
3 Month
-35.90%
-35.90%
6 Month
-8.87%
-8.87%
1 Year
+76.37%
+76.37%

More News

Read More
Tango Therapeutics Announces Discontinuation of TNG348 Program
From Tango Therapeutics
Via Business Wire
TNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
From Tango Therapeutics, Inc.
Via Business Wire
Recap: Tango Therapeutics Q4 Earnings
Via Benzinga
Tango Therapeutics: Q3 Earnings Insights
Via Benzinga
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Tango Therapeutics, Inc.
Via Business Wire
TNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
From Tango Therapeutics, Inc.
Via Business Wire
Tango Therapeutics to Participate in Upcoming Investor Conferences
From Tango Therapeutics, Inc.
Via Business Wire
Pancreatic Cancer Treatments Poised for Major Advances in 2024
Via FinancialNewsMedia
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Shares of Tango Therapeutics Are Dropping Monday
Via The Motley Fool
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Chart Of The Day: Tango Therapeutics - What Happens When The FDA Gives A Thumbs UP!
Via Talk Markets
Exposures Product Safety
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Shares of Tango Therapeutics Climbed This Week
Via The Motley Fool
Exposures Product Safety
Oracle, Sight Sciences And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Industry ETFs In The Spotlight: Winners And Losers Of The Month Revealed
Via Benzinga
Topics ETFs
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
HEICO, Canaan And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Up 126% in 3 Days, Is Tango Therapeutics a Buy Right Now?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.